e-Meet Joseph Payne, President & CEO of @ArcturusRx at #Sachs_BEF

More info @ https://t.co/pRRDWq9nmY#Sachs_BEF #lifesciences #partnering #bd #licensing #health #investment #healthcare #Arcturus #ArcturusRx #mRNA #Clinicaltrials #Vaccine #Covid19 #Coronavirus #Rarediseases pic.twitter.com/N4A78Ayryu

— Sachs Associates (@SachsAssociates) September 1, 2021